Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.52% Nasdaq Up0.28%

More On GLENMARK.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Glenmark Pharmaceuticals Ltd. (GLENMARK.NS)

-NSE

573.65 Up 1.60(0.28%) 5:59AM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2010Mar 30, 2009Mar 30, 2008Mar 30, 2007
Total Revenue 25,291,000   21,241,000   19,800,000   12,241,000  
Cost of Revenue9,463,000  8,122,000  6,126,000  4,040,000  
Gross Profit 15,828,000   13,119,000   13,674,000   8,201,000  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative -   -   -   -  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses19,514,000  17,330,000  12,424,000  8,373,000  
Operating Income or Loss 5,778,000   3,911,000   7,376,000   3,867,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes5,778,000  3,911,000  7,376,000  3,867,000  
Interest Expense(1,655,000)(1,457,000)(710,000)(398,000)
Income Before Tax -   -   -   -  
Income Tax Expense529,000  754,000  794,000  513,000  
Minority Interest(66,000)(18,000) -   -  
Net Income From Continuing Ops3,245,000  1,917,000  6,321,000  3,101,000  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 3,245,000   1,917,000   6,321,000   3,101,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares -   -   -   -  

Currency in INR.